Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QDPR | P09417 | 2/20 | 0.71 |
| ▸ | HTR2C | P28335 | 12/20 | 0.54 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.43 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18262830 | 0.87 | QDPR (0.52) | QDPR | |
| SCHEMBL17395615 | 0.86 | QDPR (0.71) | QDPRHTR2CSLC18A3SIGMAR1TLR9 | |
| SCHEMBL14300550 | 0.83 | QDPR (0.49) | QDPR | |
| SCHEMBL2709718 | 0.83 | HTR2C (0.59) | QDPRHTR2CSLC18A3SIGMAR1TLR9 | |
| SCHEMBL16736858 | 0.83 | ACMSD (0.51) | QDPR | |
| SCHEMBL8385390 | 0.83 | QDPR (1.00) | QDPRHTR2CSLC18A3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL4881862 | 0.81 | HTR2C (0.61) | QDPRHTR2CSLC18A3SIGMAR1TLR9 | |
| SCHEMBL22313839 | 0.81 | ACMSD (0.53) | QDPR | |
| SCHEMBL3357755 | 0.81 | ACMSD (0.53) | QDPR | |
| SCHEMBL29890620 | 0.81 | ACMSD (0.53) | QDPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731223-A1 | MORPHOLINE AND 1,4-OXAZEPANE COMPOUNDS AND ITS USE IN THERAPY | Universitat De Barcelona (ES) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024261340-A1 | MORPHOLINE AND 1,4-OXAZEPANE COMPOUNDS AND ITS USE IN THERAPY | UNIVERSITAT DE BARCELONA (ES) | 2024-12-26 | — | — | WO | disclosed |